Brean Murray Carret & Co. Downgrades Vivus (VVUS); Qsymia Approval Huge, But Struggling with Valuation Until Launch Proves Otherwise
Tweet Send to a Friend
Brean Murray Carret & Co. downgraded Vivus (NASDAQ: VVUS) from Buy to Hold. $30 price target removed.
Analyst, Jonathan ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Analyst, Jonathan ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
